XMALON (Aromasin) contains the active ingredient exemestane, a steroidal aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.
USES
Breast cancer in postmenopausal.
GUARANTEE & EXPIRY DATE 100% original from various Indian pharmaceutical manufacturers. Product photo may vary. All packs are air tight sealed and expire up to 02.2028.
DESCRIPTION
XMALON is indicated for the adjuvant treatment of estrogen receptor-positive early breast cancer in postmenopausal women, especially after completing 2 to 3 years of tamoxifen therapy, to complete a total of five years of hormonal treatment. It is also used for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen treatment. It lowers estrogen levels in the body by irreversibly inhibiting the aromatase enzyme, which converts androgens into estrogens. This reduction limits the growth stimulus for estrogen-dependent breast cancer cells.
Benefits:
Effectively reduces estrogen levels to slow or stop growth of hormone receptor-positive breast cancer.
Can be used sequentially after tamoxifen for enhanced reduction of breast cancer recurrence risk.
Generally well tolerated with a tolerable side effect profile compared to some other hormonal treatments.
Standard dose: 25 mg once daily orally after a meal.
Treatment duration varies; often prescribed to complete five years of total hormonal therapy or continued as long as benefit is evident in advanced disease.
VIDEO
SIDE EFFECTS AND PRECAUTIONS
Hot flashes, fatigue, increased sweating, nausea, headache, joint pain, and increased risk of osteoporosis.
Bone health monitoring advised due to decreased estrogen; use effective contraception in women of reproductive potential.
STORAGE Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
AROMASIN® (Exemestane) is used to treat advanced-stage or metastatic hormone-receptor-positive breast cancer in postmenopausal women and early-stage breast cancer in postmenopausal women after...
FARESTON (Toremifene) is used to treat metastatic breast cancer (cancer that has spread) that is hormone-receptor positive in women who have already stopped menstruating (postmenopausal). Many of the...
RANQUILON is being developed as a therapy for anxiety related to neurasthenia and adjustment disorders. It helps to manage symptoms of anxiety, Alzheimer’s disease or cognitive impairment...
OMEPRAZOLE has effect on H+-K+-ATPase activity in parietal cells, inactivates the final stage in gastric acid secretion and is used to treat gastric ulcer. Omeprazole is also prescribed for...
